BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 33431042)

  • 1. Evaluation of deep and shallow learning methods in chemogenomics for the prediction of drugs specificity.
    Playe B; Stoven V
    J Cheminform; 2020 Feb; 12(1):11. PubMed ID: 33431042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep Learning-Based Modeling of Drug-Target Interaction Prediction Incorporating Binding Site Information of Proteins.
    D'Souza S; Prema KV; Balaji S; Shah R
    Interdiscip Sci; 2023 Jun; 15(2):306-315. PubMed ID: 36967455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Employing Molecular Conformations for Ligand-Based Virtual Screening with Equivariant Graph Neural Network and Deep Multiple Instance Learning.
    Gu Y; Li J; Kang H; Zhang B; Zheng S
    Molecules; 2023 Aug; 28(16):. PubMed ID: 37630234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALDPI: adaptively learning importance of multi-scale topologies and multi-modality similarities for drug-protein interaction prediction.
    Hu K; Cui H; Zhang T; Sun C; Xuan P
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35108362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A chemogenomics view on protein-ligand spaces.
    Strömbergsson H; Kleywegt GJ
    BMC Bioinformatics; 2009 Jun; 10 Suppl 6(Suppl 6):S13. PubMed ID: 19534738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A deep neural network approach to predicting clinical outcomes of neuroblastoma patients.
    Tranchevent LC; Azuaje F; Rajapakse JC
    BMC Med Genomics; 2019 Dec; 12(Suppl 8):178. PubMed ID: 31856829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active learning for computational chemogenomics.
    Reker D; Schneider P; Schneider G; Brown JB
    Future Med Chem; 2017 Mar; 9(4):381-402. PubMed ID: 28263088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-protein binding motifs mining with a new hybrid deep learning based cross-domain knowledge integration approach.
    Pan X; Shen HB
    BMC Bioinformatics; 2017 Feb; 18(1):136. PubMed ID: 28245811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set.
    Lenselink EB; Ten Dijke N; Bongers B; Papadatos G; van Vlijmen HWT; Kowalczyk W; IJzerman AP; van Westen GJP
    J Cheminform; 2017 Aug; 9(1):45. PubMed ID: 29086168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting protein-ligand binding residues with deep convolutional neural networks.
    Cui Y; Dong Q; Hong D; Wang X
    BMC Bioinformatics; 2019 Feb; 20(1):93. PubMed ID: 30808287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boosting compound-protein interaction prediction by deep learning.
    Tian K; Shao M; Wang Y; Guan J; Zhou S
    Methods; 2016 Nov; 110():64-72. PubMed ID: 27378654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-modality attribute learning-based method for drug-protein interaction prediction based on deep neural network.
    Dong W; Yang Q; Wang J; Xu L; Li X; Luo G; Gao X
    Brief Bioinform; 2023 May; 24(3):. PubMed ID: 37114624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benchmarking a Wide Range of Chemical Descriptors for Drug-Target Interaction Prediction Using a Chemogenomic Approach.
    Sawada R; Kotera M; Yamanishi Y
    Mol Inform; 2014 Dec; 33(11-12):719-31. PubMed ID: 27485418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BACPI: a bi-directional attention neural network for compound-protein interaction and binding affinity prediction.
    Li M; Lu Z; Wu Y; Li Y
    Bioinformatics; 2022 Mar; 38(7):1995-2002. PubMed ID: 35043942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Representation Learning From Heterogeneous Data Sources and Knowledge Graphs Using Deep Collective Matrix Factorization: Evaluation Study.
    Kumar S; Nanelia A; Mariappan R; Rajagopal A; Rajan V
    JMIR Med Inform; 2022 Jan; 10(1):e28842. PubMed ID: 35049514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting drug-drug interactions using multi-modal deep auto-encoders based network embedding and positive-unlabeled learning.
    Zhang Y; Qiu Y; Cui Y; Liu S; Zhang W
    Methods; 2020 Jul; 179():37-46. PubMed ID: 32497603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient multi-task chemogenomics for drug specificity prediction.
    Playe B; Azencott CA; Stoven V
    PLoS One; 2018; 13(10):e0204999. PubMed ID: 30286165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of Deep and Shallow Neural Networks, the Universal Approximation Theorem, Activity Cliffs, and QSAR.
    Winkler DA; Le TC
    Mol Inform; 2017 Jan; 36(1-2):. PubMed ID: 27783464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational chemogenomics: is it more than inductive transfer?
    Brown JB; Okuno Y; Marcou G; Varnek A; Horvath D
    J Comput Aided Mol Des; 2014 Jun; 28(6):597-618. PubMed ID: 24771144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound-protein interaction prediction with end-to-end learning of neural networks for graphs and sequences.
    Tsubaki M; Tomii K; Sese J
    Bioinformatics; 2019 Jan; 35(2):309-318. PubMed ID: 29982330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.